The Effect of KATP Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers
BackgroundCalcitonin gene-related peptide (CGRP) dilates cranial arteries and triggers headache. The CGRP signaling pathway is partly dependent on activation of ATP-sensitive potassium (KATP) channels. Here, we investigated the effect of the KATP channel blocker glibenclamide on CGRP-induced headach...
Main Authors: | Hande Coskun, Fatima Azzahra Elbahi, Mohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Majid Sheykhzade, Messoud Ashina |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2021.652136/full |
Similar Items
-
Debate: Are cluster headache and migraine distinct headache disorders?
by: Mohammad Al-Mahdi Al-Karagholi, et al.
Published: (2022-11-01) -
The vascular effect of glibenclamide: A systematic review
by: Mohammad Al-Mahdi Al-Karagholi, et al.
Published: (2019-11-01) -
Recurrent and persistent hypoglycemia following intoxication
with glibenclamide overdose: case report
Published: (2021-08-01) -
EFFICANCY OF GLIBENCLAMIDE FOR THE CONTROL OF GESTATIONAL DIABETES MELLITUS
by: Quddsia Tanveer, et al.
Published: (2015-03-01) -
Assessment of glibenclamide pharmacokinetics in poloxamer 407-induced hyperlipidemic rats
by: Yousef A. Bin Jardan, et al.
Published: (2021-07-01)